Investigational Site Number 380004

Bologna 40138

0 studies enrolling now · 3 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Malignant Solid Tumors, Type 2 Diabetes Mellitus

Studies at this site

• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications — Completed
• SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients — Completed
• Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors — Completed